Cassel Salpeter & Co. and its leadership team are routinely contacted by the news media to comment on investment banking, M&A and general trends affecting middle-market businesses.
Cassel Salpeter & Co. is an Independent Investment banking firm that provides advice to middle-market and emerging growth companies.
Get In Touch
Cassel Salpeter & Co.
801 Brickell Avenue,
Suite 1900
Miami, FL 33131
(305) 438-7700
Stay Informed
Sign up today for insights and growth strategies.
Subscribe Now
Cassel Salpeter & Co. Facilitates Sale of Bird Global Inc. Assets to Third Lane Mobility Inc. For $145 Million in Micromobility Firm’s Chapter 11 Bankruptcy
Cassel Salpeter & Co., an independent investment banking firm that provides advisory services to middle market and emerging growth companies in the United States and worldwide, today announced that it has successfully facilitated the sale in a Chapter 11 363 sale process of substantially all of the assets of Bird Global Inc. (“Bird” or the “Company”), one of the largest micromobility operators in North America and abroad to Third Lane Mobility Inc. for approximately $145 million.
Flying cars are coming! Here’s how they could change the way you travel.
South Florida Aviation Investment Banker on Future of Air Taxis
Cassel Salpeter’s Joey Smith on when eVTOLs will take to our skies
QEP Completes Sale Of Australia/New Zealand Business
South Florida Investment Bank Advises QEP in Completing Asset Sale
Cassel Salpeter advises in finalizing sale of Boca Raton company’s operating subsidiaries abroad
QEP Agrees To Sell Australia/New Zealand Business
South Florida Investment Bank Advises in QEP Asset Sale
Cassel Salpeter advises committee in sale of Boca Raton company’s operating subsidiaries abroad
Add-On Deals Will Drive 2024 Middle Market M&A
South Florida Investment Bank Cofounder on 2024
Cassel Salpeter chairman sees middle market deal opportunities ahead
Biotech Gets Creative to Avoid Bankruptcy in 2024
South Florida Investment Bankers on Biotech Bear Market
Cassel Salpeter’s experts on how biotech companies can navigate tough market
Athersys Adds to Surge of Biotechs Filing for Bankruptcy, Sells to Healios
South Florida Investment Banker on Biotech Bankruptcies
Cassel Salpeter investment banker on factors driving biotech Ch. 11
Bird Enters into Comprehensive Restructuring Support Agreement with First- and Second-Lien Lenders to Strengthen Financial Position
Bird has sufficient liquidity to meet financial obligations to city partners, vendors, suppliers, and employees during and after the restructuring process, and will operate as usual Agreement has unanimous support of first- and second-lien lenders Apollo Global Management and second-lien lenders to provide $25 million in DIP financing
Patriot Transportation and United Petroleum Transports to Combine
Patriot Transportation Holding, Inc. (NASDAQ:PATI) (“Patriot” or the “Company”), today announced an agreement under which United Petroleum Transports, Inc. (“UPT”) will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash.
Biotech Bankruptcies Skyrocket
South Florida Investment Bankers Discuss Biotech Bankruptcies
Cassel Salpeter’s James Cassel and Ira Leiderman on healthcare industry drivers
QEP Completes Sale of United Kingdom Business
Florida Investment Bank Advises Board on Sale of UK Biz
Sale of QEP’s UK tool and accessory business assisted by Cassel Salpeter
Dry Powder Reserves Point to Insatiable Buyout Demand
Cassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
Why Biopharma Companies Buy Stock in One Another
Cassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Dealflow Continues to Drop, But Some are Optimistic for a Bounceback This Fall
Cassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
IRA Creates Unintended Complications for Biologics
Cassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Humira Biosimilars and Others Face Uncertain Future Under IRA
Cassel Salpeter Healthcare Investment Banker Weighs IRA Impacts
South Florida investment bank managing director discusses future of biosimilars after IRA
Blue Water Biotech makes the case for better mpox vaccines, even at ‘hyperlow endemicity’
Cassel Salpeter Healthcare Investment Banker Talks Mpox Vaccine
South Florida investment bank managing director considers viability of mpox vaccine development
‘We Don’t Have Enough of an Infrastructure’: Psychiatric Hospitals Buckling Under Historic Pressure
Cassel Salpeter Chairman and Cofounder Addresses Psychiatric Care Closings
South Florida investment banker James Cassel discusses what’s driving psychiatric services shutdowns
‘If There Is a Chilling Effect, It’ll Be Very Temporary’: What CARD’s Bankruptcy Means for the Autism Industry
Cassel Salpeter Chairman and Cofounder on CARD Bankruptcy
South Florida investment banker James Cassel discusses industry impacts of autism center Ch. 11
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
South Florida Investment Bank Assists Global Cancer Therapy Creator in Bankruptcy
Cassel Salpeter provides investment banking services to biopharmaceutical company Athenex in Chapter 11